Papers

4

Total Citations

58

H-Index

3

About

Dr. Sarah E. Paraghamian is a leading gynecologic oncologist whose research focuses on advancing minimally invasive surgical techniques to improve both oncologic and reproductive outcomes for women with gynecologic cancers. Her most impactful work includes a landmark international multicenter study on robot-assisted radical trachelectomy for early-stage cervical cancer, which demonstrated that fertility-sparing surgery can achieve excellent long-term oncologic safety while preserving childbearing potential—a finding that has shaped clinical practice worldwide (32 citations). Dr. Paraghamian has also made significant contributions to the management of advanced ovarian cancer, comparing laparotomy with robot-assisted interval debulking surgery following neoadjuvant chemotherapy. Her research consistently shows that robotic approaches reduce postoperative morbidity without compromising survival outcomes, offering patients faster recovery and fewer complications. Additionally, she has investigated rare complications of robotic gynecologic surgery, such as bilateral otorrhagia from patient positioning, enhancing surgical safety protocols. With over 60 total citations, Dr. Paraghamian’s work bridges the critical gap between aggressive cancer treatment and quality of life, making her a respected voice in the field of minimally invasive gynecologic oncology.

Research Focus

Key Achievements

3
H-Index
4
Papers
58
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study
32 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: University of North Carolina at Chapel Hill, University of California, Irvine Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago